Finding accredited CPD
This educational series provides an overview of managing chronic spontaneous urticaria and the emerging therapies such as BTK inhibitors, anti-IL-4Rα agents, or mast cell-targeted drugs which could offer personalised, biomarker-driven approaches that may improve disease control and provide remission. It also includes guiding commentary from Dr Annika Smith, a Fellow of the Australasian College of Dermatologists and Consultant Dermatologist in public and private settings in Sydney.
This educational series provides an overview of managing chronic spontaneous urticaria and the emerging therapies such as BTK inhibitors, anti-IL-4Rα agents, or mast cell-targeted drugs which could offer personalised, biomarker-driven approaches that may improve disease control and provide remission.
This activity is accepted by CPD Home as Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.
Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)
